Ortin Global Limited Asset Resilience Ratio

Latest as of September 2024: 2.07%

Ortin Global Limited asset resilience ratio. Ortin Global Limited (ORTINGLOBE) has an Asset Resilience Ratio of 2.07% as of September 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See how many days can Ortin Global Limited fund operations to measure how many days the company can operate on defensive assets alone.

Liquid Assets

Rs833.00K
≈ $9.01K USD Cash + Short-term Investments

Total Assets

Rs40.31 Million
≈ $435.94K USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio of Ortin Global Limited (2021–2024)

Asset resilience ratio of Ortin Global Limited from 2021 to 2024. This chart shows how Ortin Global Limited's Asset Resilience Ratio has changed over time. Read ORTINGLOBE current and long-term liabilities for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Ortin Global Limited's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see ORTINGLOBE total assets.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents Rs0.00 0%
Short-term Investments Rs833.00K 2.07%
Total Liquid Assets Rs833.00K 2.07%

Asset Resilience Insights

  • Limited Liquidity: Ortin Global Limited maintains only 2.07% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Ortin Global Limited Industry Peers by Asset Resilience Ratio

Compare Ortin Global Limited's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Jiangsu Nhwa Pharmaceutical Co Ltd
SHE:002262
Drug Manufacturers - Specialty & Generic 26.45%
Tibet Rhodiola Pharmaceutical Holding Co
SHG:600211
Drug Manufacturers - Specialty & Generic 11.84%
Shanghai Yizhong Pharmaceutical Co Ltd
SHG:688091
Drug Manufacturers - Specialty & Generic 26.36%
Renhe Pharmacy Co Ltd
SHE:000650
Drug Manufacturers - Specialty & Generic 37.54%
Bide Pharmatech Co. Ltd. A
SHG:688073
Drug Manufacturers - Specialty & Generic 9.46%
Jianmin Pharmaceutical Group Co Ltd
SHG:600976
Drug Manufacturers - Specialty & Generic 20.61%
Qianjiang Yongan Pharmaceutical Co Ltd
SHE:002365
Drug Manufacturers - Specialty & Generic 30.38%
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078
Drug Manufacturers - Specialty & Generic 0.42%

Ortin Global Limited Asset Resilience Ratio by Year (2021–2024)

Ortin Global Limited asset resilience ratio by year from 2021 to 2024. The table below shows the annual Asset Resilience Ratio data for Ortin Global Limited.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2024-03-31 28.26% Rs18.83 Million
≈ $203.67K
Rs66.64 Million
≈ $720.72K
+28.09pp
2023-03-31 0.17% Rs361.00K
≈ $3.90K
Rs211.97 Million
≈ $2.29 Million
-0.33pp
2022-03-31 0.50% Rs1.03 Million
≈ $11.16K
Rs207.05 Million
≈ $2.24 Million
-0.21pp
2021-03-31 0.71% Rs1.51 Million
≈ $16.32K
Rs212.66 Million
≈ $2.30 Million
--
pp = percentage points

About Ortin Global Limited

NSE:ORTINGLOBE India Drug Manufacturers - Specialty & Generic
Market Cap
$1.15 Million
Rs106.03 Million INR
Market Cap Rank
#30576 Global
#1689 in India
Share Price
Rs13.04
Change (1 day)
-4.19%
52-Week Range
Rs11.19 - Rs19.92
All Time High
Rs19.92
About

Ortin Global Limited engages in the manufacture and trading of pharmaceuticals, drugs, and intermediates in India. The company offers various pharmaceutical formulations of tablets, capsules, syrups, and dry powders; formulations, such as anti-diabetics, anti-allergics, anti-anginal and cardiovascular, sedatives and tranquilisers, anti-helmenthetics, analgesics and antipyretics, anti-biotics-quin… Read more